» Articles » PMID: 30402223

Understanding Psoriasis: Role of MiRNAs

Overview
Journal Biomed Rep
Specialty Biochemistry
Date 2018 Nov 8
PMID 30402223
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is a chronic, immune-mediated inflammatory skin disease, with a multifactorial etiology and important immunologic, genetic and environmental components. Psoriasis vulgaris represents its most common form, with a variable prevalence across the globe. Although its pathogenesis remains to be fully elucidated, a lack of balance in the epigenetic network has been shown to trigger certain elements of this disease, possibly altering its outcome. MicroRNAs are small non-coding RNA molecules involved in RNA-silencing and the post-transcriptional regulation of gene expression, which also appear to mediate the immune dysfunction in psoriasis. Although microRNA research is a new field in dermatology and psoriasis, there is rapidly accumulating evidence for its major contribution in the pathogenesis of chronic inflammatory conditions, including psoriasis and other dermatological disorders. Furthermore, circulating miRNAs identified in patients' blood samples have been identified as promising biomarkers of diagnosis, prognosis or treatment response. Extended investigations in this field are required, as until now, the exact involvement of miRNAs in psoriasis have remained to be entirely elucidated. This short review highlights a number of the roles of miRNAs found in different stages of psoriasis.

Citing Articles

MicroRNA-146a Signature in Psoriasis: A Systematic Review and Meta-Analysis.

Ho P, Huang Y Mol Diagn Ther. 2024; 28(4):379-388.

PMID: 38773009 DOI: 10.1007/s40291-024-00714-0.


Intrinsic Effects of Exposome in Atopic Dermatitis: Genomics, Epigenomics and Regulatory Layers.

Grafanaki K, Antonatos C, Maniatis A, Petropoulou A, Vryzaki E, Vasilopoulos Y J Clin Med. 2023; 12(12).

PMID: 37373692 PMC: 10299550. DOI: 10.3390/jcm12124000.


The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases-A Review.

Dopytalska K, Czaplicka A, Szymanska E, Walecka I Int J Mol Sci. 2023; 24(11).

PMID: 37298095 PMC: 10253000. DOI: 10.3390/ijms24119130.


InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study.

Diotallevi F, Matacchione G, DAgostino G, Gioacchini H, Campanati A, Sabbatinelli J Dermatol Ther (Heidelb). 2023; 13(6):1377-1387.

PMID: 37198526 PMC: 10264314. DOI: 10.1007/s13555-023-00931-1.


The Impact of Diet and Physical Activity on Psoriasis: A Narrative Review of the Current Evidence.

Duchnik E, Kruk J, Tuchowska A, Marchlewicz M Nutrients. 2023; 15(4).

PMID: 36839198 PMC: 9958594. DOI: 10.3390/nu15040840.


References
1.
Xu N, Meisgen F, Butler L, Han G, Wang X, Soderberg-Naucler C . MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol. 2012; 190(2):678-88. DOI: 10.4049/jimmunol.1202695. View

2.
Lerman G, Avivi C, Mardoukh C, Barzilai A, Tessone A, Gradus B . MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS One. 2011; 6(6):e20916. PMC: 3110257. DOI: 10.1371/journal.pone.0020916. View

3.
Srivastava A, Nikamo P, Lohcharoenkal W, Li D, Meisgen F, Landen N . MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis. J Allergy Clin Immunol. 2016; 139(2):550-561. DOI: 10.1016/j.jaci.2016.07.025. View

4.
Van Gele M, Bracke S, Alves De Medeiros A, Lambert J . Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate to severe psoriasis. Eur J Dermatol. 2016; 26(2):195-8. DOI: 10.1684/ejd.2015.2710. View

5.
Wang M, Xu Y, Huang R, Chen X, Chen H, Han L . Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literature. Oncotarget. 2016; 8(3):5498-5507. PMC: 5354926. DOI: 10.18632/oncotarget.12534. View